NYSE:RVTYLife Sciences
Revvity Expands Automation Platforms At SLAS2026 As Investors Weigh Long Term Upside
Revvity (NYSE:RVTY) introduced several new discovery and automation platforms at SLAS2026.
The company showcased the Opera Phenix OptIQ high content screening system, EnVision Nexus One plate reader, and AssayMate workstation.
Revvity also highlighted collaborations around automated next generation sequencing workflows at the event.
Revvity, which focuses on life science tools and diagnostics, is pushing deeper into high throughput drug discovery and lab automation with these SLAS2026...